✦ LIBER ✦

Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia

✍ Scribed by Pavel Dvorak; Martina Hruba; Ivan Subrt

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 288 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.09.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

t(3;21)(q26;q22) in myeloid leukemia : A

t(3;21)(q26;q22) in myeloid leukemia : An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

✍ C. Cameron Yin; Jorge Cortes; Bedia Barkoh; Kimberly Hayes; Hagop Kantarjian; Da 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Inv (11)(p15q21) in donor-derived Ph-neg

Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation

✍ Bruno C. Medeiros; Kathy Chun; Suzanne Kamel-Reid; Jeffrey Lipton 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract Imatinib mesylate (IM) is the standard first‐line treatment for patients with chronic myeloid leukemia (CML). Surprisingly, 2–15% of patients achieving a complete cytogenetic response develop cytogenetic abnormalities in Philadelphia (Ph)‐negative cells. Following hematopoietic stem cel

Development of a dual-color, double fusi

Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia

✍ Brandon M. Shearer; William R. Sukov; Heather C. Flynn; Ryan A. Knudson; Rhett P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 845 KB